
Retatrutide 10mg Research Vial
Retatrutide 10mg is a lyophilised research peptide supplied as a single, sealed vial for controlled in vitro studies of metabolic signalling.
Tirzepatide 10mg is a lyophilised dual-receptor peptide supplied in a sealed vial for in vitro metabolic research.

Tirzepatide 10mg is a lyophilised dual-receptor peptide supplied in a sealed vial for in vitro metabolic research.
Price shown is for a single 10mg vial. The final amount is confirmed at checkout. Need a different amount? Send an inquiry.
Tirzepatide 10mg is a lyophilised dual-receptor peptide supplied in a sealed vial for in vitro metabolic research. Tirzepatide is studied for how dual agonism at the GIP and GLP-1 receptors relates to metabolic pathways in cell models. The 10mg vial is the smallest strength in the range, suitable for pilot assays and smaller studies. It arrives as a freeze-dried powder, sealed and labelled with the 10mg nominal amount, with CAS 2023788-19-2 recorded for reference. The batch report documents identity and purity for the lot. AthloPep provides it for research use only, not as a medicine or for human weight management. This listing is for the 10mg vial. The material is identified by CAS number 2023788-19-2.
| Labelled amount | 10mg |
|---|---|
| Form | Lyophilised powder |
| CAS number | 2023788-19-2 |
| Intended use | In vitro laboratory research |
Every vial is supplied with an analytical report prepared for its own batch. The report records identity and purity results for the submitted sample. Match the batch identifier on the report to the vial you receive before use.
Tirzepatide 10mg is a lyophilised dual-receptor peptide supplied in a sealed vial for in vitro metabolic research. It is supplied as a lyophilised, sealed research vial and is not a medicine.
The vial is labelled with a nominal 10mg of material. The figure is the stated content of the vial, not a solution concentration, and should be checked against the batch documentation before use.
Yes. Each listing links to the analytical report prepared for the specific batch. The report records identity and purity results for the submitted sample and should be matched to the vial you receive.
It arrives as a freeze-dried powder in a sealed vial. Keep the container closed and follow the storage conditions printed on the label and any handling sheet supplied with the lot.
No. AthloPep supplies this material for in vitro laboratory research only. It is not for human or animal consumption and no therapeutic use is implied.
The listed unit price for this vial is $79.2. Prices are shown in US dollars and the final amount is confirmed on the checkout page before payment.

Retatrutide 10mg is a lyophilised research peptide supplied as a single, sealed vial for controlled in vitro studies of metabolic signalling.

Retatrutide 15mg is a lyophilised research peptide supplied as a single, sealed vial for metabolic receptor studies in vitro.

Retatrutide 20mg is a lyophilised research peptide in a sealed vial, intended for laboratory studies of metabolic and receptor pathways.

Retatrutide 30mg is a sealed, lyophilised research vial for in vitro work on metabolic receptor signalling.
Tell us what you need. An email address is required so we can reply.